| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Kaye Randall serves as a Chief Medical Officer at AXSM. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $1.3M at current prices.
The biggest single holding is AXSM (~$1.3M) as Chief Medical Officer. Net of sales, the recent Form 4 record there shows accumulation of 1,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2015 | AXSM Axsome Therapeutics, Inc. | Chief Medical Officer | Buy | 1,000 | $9.03 | $9,026.00 | +19.9% |